COM:HEPIONPHARMA
Hepion Pharmaceuticals
- Stock
Last Close
0.69
22/11 21:00
Market Cap
5.64M
Beta: -
Volume Today
19.61K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Jun '14 | Jun '15 | Jun '16 | Jun '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
net income | -5.28M - | -14.35M 171.70% | -17.00M 18.47% | -14.89M 12.40% | -9.45M 36.54% | -7.04M 25.53% | -20.35M 189.23% | -32.72M 60.77% | -42.20M 28.96% | -48.93M 15.94% | |
depreciation and amortization | 1.32K - | 16.36K 1,138.08% | 21.52K 31.61% | 27.99K 30.05% | 18.79K 32.89% | 26.74K 42.32% | 34.52K 29.09% | 86.07K 149.38% | 77.46K 10.01% | 67.13K 13.34% | |
deferred income tax | 387.90K - | -4.22M - | -536K 87.31% | 48.32K 109.02% | 6.05K 87.48% | 1.87M - | -409.02K 121.86% | ||||
stock based compensation | 195.23K - | 2.12M 984.99% | 901.87K 57.42% | 1.70M 88.52% | 234.51K 86.21% | 66.18K 71.78% | 2.38M 3,495.50% | 4.67M 96.22% | 2.55M 45.32% | 1.34M 47.50% | |
change in working capital | 125.43K - | 952.88K 659.70% | 3.33M 249.15% | -1.84M 155.32% | -970.48K 47.27% | -826.23K 14.86% | 1.63M 297.14% | -5.57M 441.80% | 3.15M 156.63% | 302.92K 90.39% | |
accounts receivables | |||||||||||
inventory | |||||||||||
accounts payables | -317.05K - | 3.04M 1,058.61% | 302.92K - | ||||||||
other working capital | -970.48K - | -509.19K 47.53% | -1.41M 177.00% | -5.57M 294.72% | -302.92K - | ||||||
other non cash items | 3.60M - | 1.59M 55.84% | -3.81M 339.74% | -4.17M 9.50% | -4.94M 18.59% | 157.28K 103.18% | 140K 10.99% | 2.31M 1,550% | 1.46M 36.97% | 6.74M 362.65% | |
net cash provided by operating activities | -1.36M - | -9.67M 609.61% | -16.56M 71.16% | -19.17M 15.81% | -15.65M 18.39% | -7.57M 51.65% | -16.17M 113.68% | -31.22M 93.16% | -34.96M 11.97% | -40.89M 16.96% | |
investments in property plant and equipment | -15.85K - | -83.27K 425.46% | -6.60K 92.07% | -14.71K 122.76% | -51.47K - | -87.98K 70.94% | -130.41K 48.22% | -16.34K 87.47% | -14.30K 12.44% | ||
acquisitions net | -495.60K - | 2.19K - | |||||||||
purchases of investments | |||||||||||
sales maturities of investments | |||||||||||
other investing activites | 2.27K - | ||||||||||
net cash used for investing activites | -15.85K - | -83.27K 425.46% | -502.21K 503.11% | -14.71K 97.07% | 900 106.12% | -51.47K 5,818.78% | -85.79K 66.68% | -130.41K 52.01% | -14.07K 89.21% | -14.30K 1.66% | |
debt repayment | -450K - | -10.41K - | -668.94K 6,325.96% | -2.37M 254.20% | -176.59K 92.55% | -176.59K 0% | |||||
common stock issued | 3.23M - | 24.66M - | 1.64M 93.37% | 7.68M 369.90% | 42.87M 457.90% | 82.15M 91.65% | 4.49M - | ||||
common stock repurchased | -21M - | ||||||||||
dividends paid | -1K - | ||||||||||
other financing activites | 334.97K - | 116.28K - | 11.56M 9,839.49% | 13.39M 15.88% | 188.59K 98.59% | 15.86M - | 1K 99.99% | ||||
net cash used provided by financing activities | 3.11M - | 12.50M 301.97% | 19.90M 59.17% | 24.77M 24.46% | 12.52M 49.43% | 18.71M 49.38% | 43.05M 130.15% | 81.98M 90.40% | -5.14M 106.27% | 4.49M 187.49% | |
effect of forex changes on cash | -47.14K - | 5.02K 110.66% | |||||||||
net change in cash | 1.73M - | 2.75M 58.60% | 2.84M 3.47% | 5.58M 96.38% | -3.12M 155.95% | 11.09M 455.29% | 26.80M 141.68% | 50.62M 88.86% | -40.16M 179.33% | -36.40M 9.35% | |
cash at beginning of period | 86.72K - | 1.82M 1,996.22% | 4.56M 151.03% | 7.40M 62.25% | 5.95M 19.58% | 2.83M 52.43% | 13.92M 391.56% | 40.73M 192.52% | 91.35M 124.30% | 51.19M 43.96% | |
cash at end of period | 1.82M - | 4.56M 151.03% | 7.40M 62.25% | 12.98M 75.35% | 2.83M 78.18% | 13.92M 391.56% | 40.73M 192.52% | 91.35M 124.30% | 51.19M 43.96% | 14.79M 71.12% | |
operating cash flow | -1.36M - | -9.67M 609.61% | -16.56M 71.16% | -19.17M 15.81% | -15.65M 18.39% | -7.57M 51.65% | -16.17M 113.68% | -31.22M 93.16% | -34.96M 11.97% | -40.89M 16.96% | |
capital expenditure | -15.85K - | -83.27K 425.46% | -6.60K 92.07% | -14.71K 122.76% | -51.47K - | -87.98K 70.94% | -130.41K 48.22% | -16.34K 87.47% | -14.30K 12.44% | ||
free cash flow | -1.38M - | -9.76M 607.49% | -16.56M 69.76% | -19.19M 15.85% | -15.65M 18.45% | -7.62M 51.32% | -16.25M 113.39% | -31.35M 92.92% | -34.98M 11.55% | -40.90M 16.94% |
All numbers in USD (except ratios and percentages)